This Report provided by 24 Market Reports is about, Hypertension is a serious and common medical condition characterized by elevated blood pressure. It is commonly seen in the aging population, and in people with sedentary lifestyles and obesity. As one of the most significant preventable causes of death worldwide, early diagnosis of the condition is crucial to improve health outcomes. Hypertension is the key risk factor for stroke; according to the National Stroke Association (NSA), two-thirds of patients who suffer a stroke have hypertension.
“Market Digest: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Asia-Pacific” provides quantitative analysis of the three aesthetic lasers and energy devices market segments: minimally invasive body contouring devices, non-invasive body contouring devices and laser resurfacing devices. The analysis includes market size data by revenue and volume over the 2006 - 2020 period for the following countries: China, Japan, South Korea, Australia and India See Full Report : http://bit.ly/1DpToAz
Big Market Research, Global Antihypertensives Market Size, Share, Trends, Application, Forecast, Demand, Insights, Analysis, Research, Report, Opportunities,2013 – 2020. Antihypertensives are the drugs that are used to treat high blood pressure. Increase in blood pressure is measured in terms of systolic and diastolic blood pressure exerted by blood on the wall of artery and hence it is also termed as arterial hypertension. Comprehensive coverage of global antihypertensives market along with disease overview, market trends, drivers and restraints would provide key insights to market dynamics.
Hypertension is a chronic medical condition characterized by elevated blood pressure in the arteries. It affected an estimated 517 million people in 2014, a figure that will grow at a Compound Annual Growth Rate (CAGR) of 1.2% to 561 million in 2021 in the four Asia-Pacific (APAC) regions of China, India, Australia, and Japan. This high prevalence is a substantial contributor to healthcare costs and a major cause of morbidity. Despite this, awareness of hypertension is low among physicians, patients, and the public alike, leading to poor blood pressure control.
Cardiovascular Drugs Market, by Drug Class (Anti-hyperlipidaemic, Anti-hypertensives, Anti-coagulants, Anti-arrhythmic and Others), Indication (Hypertension, Hyperlipidaemia, Coronary Artery Disease, Arrhythmia and Others), Distribution Channel (Hospital, Pharmacies and Others) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
Global Geriatric Medicine Market size was estimated to be US$ 677.5 million in 2019 and is growing at a CAGR of 6.7% during 2021 – 2028. Hastily aging population across the globe primarily in emerging and developed economies made geriatric a concern among the public health. Geriatric medicine is referred as a branch of medicine associated to preventive, healing and clinical illness for the age group belonging above 65 years. Maturing body continually tends to vulnerability and geriatric which inclines for neurological, cardiovascular and respiratory sickness. Geriatric drugs are vital part for therapeutic science giving improved diagnostic for the aging population which propels the market to thrive. Alarming chronic diseases amid geriatrics such as cancers, diabetes and arthritis attributes for market progress.
TBRC global cough and cold preparations market report includes bronchodialators, anticholinergic, pulmonary antihypertensives, antihistamines, expectorants
The global antihypertensive drugs market is estimated to garner a revenue of approximately USD 40 billion by the end of 2031 by growing at a CAGR of around ~3% over the forecast period, i.e., 2022 – 2031.
The branded generics market is expected to grow from US$ 235.86 billion in 2022 to US$ 414.99 billion by 2028; it is estimated to grow at a CAGR of 9.9% from 2022 to 2028.
The cardiovascular drugs market expected to reach a value of nearly $86.67 billion by 2022, significantly growing at a CAGR of 1.2% during the forecast period. Read more at http://bit.ly/2QtSpfa
Bharat Book presents the report on “Global Markets for Generic Drugs” (https://www.bharatbook.com/healthcare-market-research-reports-467698/global-generic-drugs3.html). It provide detailed market, technology and industry analyses to help readers quantify and qualify the market for prescription generic drugs.
Hypertension is a medical condition in which the blood pressure of an individual is elevated to a level beyond what is the desired level. As a result of this, a number of other conditions such as blood pressure and mental distress can take place.
The global algae products market size reached US$ 1.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.4 Billion by 2027, exhibiting a growth rate (CAGR) of 5.49% during 2022-2027. More info:- https://www.imarcgroup.com/algae-products-market
According to the latest research report by IMARC Group, The global algae products market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2028, exhibiting a growth rate (CAGR) of 5.3% during 2023-2028. More Info:- https://www.imarcgroup.com/algae-products-market
The Business Research Company’s Anti-Hypertensive Drugs Global Market Report 2019 covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. http://bit.ly/32hhfl7
Anti-Hypertensive Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Hypertensive Drugs market will be able to gain the upper hand as they use the report as a powerful resource.
Sedentary lifestyle is a major driver for the growth of the anti-hypertensive drugs market. Consumption of junk food, lack of proper healthy and balanced diet, lack of proper sleep due to irregular work shifts have contributed to the increase in hypertension.
Major players in the anti-hypertensive drugs market are Merck & Co. Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited, Johnson & Johnson Ltd., Pfizer Inc., Novartis AG, Sanofi SA.... @@ https://bit.ly/3wtS4uh
Hypertension is a chronic medical condition characterized by elevated blood pressure in the arteries. It affected an estimated 517 million people in 2014, a figure that will grow at a Compound Annual Growth Rate (CAGR) of 1.2% to 561 million in 2021 in the four Asia-Pacific (APAC) regions of China, India, Australia, and Japan. This high prevalence is a substantial contributor to healthcare costs and a major cause of morbidity. Despite this, awareness of hypertension is low among physicians, patients, and the public alike, leading to poor blood pressure control. Enquiry @ http://www.researchbeam.com/anti-hypertensive-therapeutics-in-asia-pacific-to-2021-increasing-prevalence-of-hypertension-drives-growth-despite-weak-pipeline-market/enquire-about-report
The global cough and cold preparations market size is expected to grow from $61.84 billion in 2021 to $66.61 billion in 2022 at a compound annual growth rate (CAGR) of 7.7%.
The cardiovascular drugs market expected to reach a value of nearly $86.67 billion by 2022, significantly growing at a CAGR of 1.2% during the forecast period. Read more at http://bit.ly/2QtSpfa
Diuretic drugs also termed as ‘water pills’ assists the kidneys eliminate extra water and concentration of sodium and chloride from the body by increasing flow of urine. Diuretic drugs are prescribed as first line drugs used solely as therapeutic agents to treat hypertension while combination with other antihypertensive drugs is used in treatment of more severe forms of hypertension. Diuretics are extensively used in treatment for people facing health concerns like hyper tension, water retention problems, liver disorders, cardiovascular diseases as well as nephrological and urological disorders.
A recent report published by TheBusinessResearchCompany on Anti-Hypertensive Drugs Market provides in-depth analysis of segments and sub-segments in the global as well as regional. http://bit.ly/36jFzF8
The growth of antihypertensive market is mainly driven by change in lifestyle, elevated stress level, and rise in prevalent population, early detection and penetration of combined dose.
The abdominal aortic aneurysm is a case in which the largest aorta of the body rupture can cause internal bleeding inside the patient’s body which can cause death. There is high demand for stent for stopping any rupture and high R&D is currently going on for drug development. There is high scope for the Abdominal Aortic Aneurysm Treatment Market in various regions across the globe during 2016-2021.
Hypertension is a chronic medical condition characterized by elevated blood pressure in the arteries. It affected an estimated 517 million people in 2014, a figure that will grow at a Compound Annual Growth Rate (CAGR) of 1.2% to 561 million in 2021 in the four Asia-Pacific (APAC) regions of China, India, Australia, and Japan.
This report provides in-depth analysis of hypertension therapeutics market within the eight major geographies of the US, the top five European countries (the UK, France, Germany, Spain and Italy), Japan and Canada. The report provides an estimation of market size for 2013, along with market forecast until 2020. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis.
Title: BIG Core Medical Education Presentation Author: SCS Healthcare Marketing, Inc. Last modified by: Birju B. Patel, M.D. Created Date: 2/14/1996 8:30:10 AM
The Pharmaceutical Composition Methodology described in this presentation has been developed to improve controlled drug delivery through site specific release of drug.
The value of the hypertension market in the major developed markets amounted to an estimated $40.0 billion in 2013 and is expected to decline during the forecast period at a negative Compound Annual Growth Rate (CAGR) of 0.9% to $37.6 billion in 2020, with growth expected from 2013 to 2017 at a CAGR of 2.6% and a decline thereafter. Detailed report at: http://www.reportsandintelligence.com/antihypertensive-therapeutics-in-major-developed-to-2020-increased-uptake-of-combination-therapies-to-offset-effects-of-key-patent-expiries-market
Cardiovascular Drugs Market by Top Key Players are Merck & Co., Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., Janssen Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Bayer AG, Novartis AG, Gilead Sciences, Inc., AstraZeneca Forecast till 2026 For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/cardiovascular-therapeutics-market-100379
Global Injectable Drug Delivery Market report available @ http://www.reportsnreports.com/reports/758272-global-injectable-drug-delivery-market-by-manufacturers-regions-type-and-application-forecast-to-2021.html . The report has been divided into key manufacturers regionally and also covered few of the other market sectors. It has also mentioned market opportunities, market risk, and market driving force.
The report provides a complete roadmap for setting up an amlodipine manufacturing plant. It covers a comprehensive market overview to micro-level information such as unit operations involved, raw material requirements, utility requirements, infrastructure requirements, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, etc.
The report provides a complete roadmap for setting up an Camel Dairy Processing Plant. It covers a comprehensive market overview to micro-level information such as unit operations involved, raw material requirements, utility requirements, infrastructure requirements, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, etc.
The report provides the latest 2014 CIF price for over 22,000 products that are categorized by pharmaceutical form, route of administration, pack size, strength, registration status and current local agent. The report also provides a qualitative analysis of trends in the Bahraini pharmaceutical market and its relation to both GCC and global markets.
The report provides a complete roadmap for setting up an clonidine manufacturing plant. It covers a comprehensive market overview to micro-level information such as unit operations involved, raw material requirements, utility requirements, infrastructure requirements, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, etc. More Info:- https://www.imarcgroup.com/clonidine-manufacturing-plant-project-report #Manufacturing #PlantSetup #IMARCGroup #PlantReport
Dear customer Aarkstore announce a new report "Aarkstore.com Research Report on China's Textile Industry, 2012 " through its vast collection of market research report
Dear customer Aarkstore announce a new report "Aarkstore.com Research Report on Chinese Food Additive Industry, 2012 " through its vast collection of market research report
September 30, 2004 Merck withdraws Vioxx (rofecoxib) from the market ... The concurrent use of aspirin and an NSAID does increase the risk of serous GI events ...
Dear customer Aarkstore announce a new report "Aarkstore.com Research Report on Chinese Medicine Intermediate Industry, 2012 " through its vast collection of market research report
Dear customer Aarkstore announce a new report "Aarkstore.com Research Report on Chinese Tobacco Additive Industry, 2012 " through its vast collection of market research report
Dear customer Aarkstore announce a new report "Aarkstore.com Research Report on Chinese Daily Necessity Additive Industry, 2012 " through its vast collection of market research report
Dear customer Aarkstore announce a new report "Aarkstore.com Research Report on Chinese Chemosynthetic Polypeptide Drug Industry, 2012 " through its vast collection of market research report
Dear customer Aarkstore announce a new report "2011-2012 Aarkstore.com Research Report on China Polysilicon Industry, 2011-2012 " through its vast collection of market research report
Seaweed has been used as a salt substitute and therefore has been used for the formulation of new sodium-reduced meat products. Seaweeds have minerals like Na, Ca, Mg, Mn, P, K, I, Fe and Zn. This high mineral content offers an enormous opportunity of using seaweeds as salt replacers in processed meat. In the present Growing market of food ingredients development, reduced-salt food products are expected to grow at a compound annual growth rate (CAGR) of 5.1% from 2022 to 2030, Food Research Lab helps you in the development of low sodium and salt substitute for cooking for a healthier lifestyle by carrying out a through ingredient analysis. Read more: https://www.foodresearchlab.com/blog/new-product-development/formulation-of-healthier-products-as-a-source-of-salt-replacers/
The report includes 1,400+ unique products that are registered across the GCC. The report also includes each item’s manufacturer, trade name, generic name, registration date, strength, dosage form and shelf life.
The 2014 CIF Unified GCC Prices Report provides a large database of all new unified CIF prices (in US dollars), along with the product's generic name, trade name, manufacturer, dosage form, pack size and concentration.
to be a less cyclical company in the current economic uncertainty ... Canada for the treatment of symptomatic gastro-esophageal reflux disease (GERD) ...
Herbal Supplements Important Facts Use of plant derived products to promote health and relieve symptoms of disease Form of alternative medicine Can be sold without a ...